Episodic Ataxia, Type 2: Clinical Trials

1 trial for Episodic Ataxia, Type 2, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Active not recruiting 1

Follow Episodic Ataxia, Type 2: new trials by email Literature Review of Episodic Ataxia, Type 2 trials Research Report on Episodic Ataxia, Type 2

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pivotal Study of N-acetyl-L-leucine for CACNA1A
N-Acetyl-L-Leucine, Placebo - CACNA1A, Spinocerebellar Ataxia Type 6
Phase 3Active not recruitingIntraBio Inc602026-08-172026-11-03

Narrower conditions

Spinocerebellar Ataxias (1)

Broader conditions

Ataxia (1)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Cerebellar Ataxia (1)  ·  Cerebellar Diseases (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Dyskinesias (1)  ·  Genetic Diseases, Inborn (1)  ·  Heredodegenerative Disorders, Nervous System (1)  ·  Nervous System Diseases (1)  ·  Neurodegenerative Diseases (1)  ·  Neurologic Manifestations (1)  ·  Spinal Cord Diseases (1)  ·  Spinocerebellar Degenerations (1)

Interventions

acetylleucine (1)

Sponsors

IntraBio Inc (1)

Countries

Austria (1)  ·  Germany (1)  ·  Greece (1)  ·  Italy (1)  ·  Switzerland (1)  ·  United Kingdom (1)  ·  United States (1)

NIH funding

2025 (1)